Display Settings:

Format

Send to:

Choose Destination
    Curr Opin Investig Drugs. 2008 Dec;9(12):1296-301.

    Therapeutic prostate cancer vaccines: a review of the latest developments.

    Source

    National Cancer Institute, Center for Cancer Research, Laboratory of Tumor Immunology and Biology, 10 Center Drive, Building 10, Room 8B09, MSC 1750, Bethesda, MD 20892-1750, USA.

    Abstract

    Therapeutic cancer vaccines are well-tolerated immunotherapy modalities designed to activate the immune system to kill cancer cells without a significant effect on healthy cells. An improved understanding of tumor immunology has led to improved strategies in vaccine development, which in turn have resulted in improved outcomes. This review discusses different types of cancer vaccines, with a focus on prostate cancer vaccines because of the high prevalence of prostate cancer and the wide variety of approaches used in prostate cancer immunotherapy.

    PMID:
    19037836
    [PubMed - indexed for MEDLINE]

      Supplemental Content

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk